ImmuneSensor Awarded $16 Million Grant from the Cancer Prevention and Research Institute of Texas…
DALLAS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- ImmuneSensor Therapeutics Inc. (“ImmuneSensor”), a private clinical-stage biotechnology company dedicated to harnessing innate immunity to treat cancer and autoimmune diseases, today announced…